Evidence map›Paper›PMID 40026569›Full record

ArticleThe journal of liquid biopsy2024

Theranostics aspect of extracellular vesicle in cancer liquid biopsy.

Shivani Ravipati, Arghya Nath, Sumitaksha Banerjee, Harendra Kumar, Vindhya Vasini Lella, Swarup Sonar, Dattatreya Mukherjee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of liquid biopsy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shivani RavipatiDr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinna Avutapalle, Gannavaram, Andhra Pradesh, 521286, India.
Arghya NathICMR-DHR Viral Research & Diagnostic Laboratory, Burdwan Medical College, Burdwan, India.
Sumitaksha BanerjeeBurdwan Medical College and Hospital, Burdwan, India.
Harendra KumarDow University of Health Science, Karachi, Sindh, 74200, Pakistan.
Vindhya Vasini LellaKonaseema Institute of Medical Sciences and Research Foundation, Chaitanya Health City, NH216, Amalapuram, Andhra Pradesh, 533201, India.
Swarup SonarGenpact, Badshahpur, Sector 69, Gurugram, Haryana, 12210, India.
Dattatreya MukherjeeRaiganj Government Medical College and Hospital, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in cancer treatment emphasize the pivotal role of extracellular vesicles (EVs), especially exosomes (a subpopulation of EVs, originating from endosomes). Exosomes are signaling molecules in the cellular system. Its molecular signature displays the status of the cell (cell healthy or undergoing any clinical complication). Exosomes are frontiers of upcoming cancer theranostics era. This article highlighted cancer exosome complex interlink, the advantage of exosome-base liquid biopsy, the effectiveness of exosome-based cell-free therapy compared to cell therapy, complications of exosome research, and its solution. Hope, this article motivated cancer researchers to explore the exosome-based precision oncology era.

Indexed as

CancerCell therapyExosomesExtracellular vesicle

Identifiers

PMID40026569
PMCPMC11863977

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.